Penelope Brock
AuthID: R-00G-R3Y
1
TÃTULO: EBMT Lessons from 40 Years of High Dose Chemotherapy (HDT) and Stem Cell Transplantation (SCT) In Neuroblastoma. A Report From the Paediatric Working Party
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Penelope Brock; Roberto Luksch; Victoria Castel; Shifra Ash; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Evgenia Glogova; Dominique Valteau Couanet; Selim Corbacioglu;
PUBLICAÇÃO: 2020, FONTE: BONE MARROW TRANSPLANTATION, VOLUME: 55, NÚMERO: SUPPL 1
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Penelope Brock; Roberto Luksch; Victoria Castel; Shifra Ash; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Evgenia Glogova; Dominique Valteau Couanet; Selim Corbacioglu;
PUBLICAÇÃO: 2020, FONTE: BONE MARROW TRANSPLANTATION, VOLUME: 55, NÚMERO: SUPPL 1
INDEXADO EM: 
WOS
WOS2
TÃTULO: Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial Full Text
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Andrew D J Pearson; Penelope Brock; Roberto Luksch; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Adela Canete; ...Mais
PUBLICAÇÃO: 2017, FONTE: LANCET ONCOLOGY, VOLUME: 18, NÚMERO: 4
AUTORES: Ruth Ladenstein; Ulrike Poetschger; Andrew D J Pearson; Penelope Brock; Roberto Luksch; Victoria Castel; Isaac Yaniv; Vassilios Papadakis; Genevieve Laureys; Josef Malis; Walentyna Balwierz; Ellen Ruud; Per Kogner; Henrik Schroeder; Ana Forjaz de Lacerda; Maja Beck Popovic; Pavel Bician; Miklos Garami; Toby Trahair; Adela Canete; ...Mais
PUBLICAÇÃO: 2017, FONTE: LANCET ONCOLOGY, VOLUME: 18, NÚMERO: 4
INDEXADO EM: WOS
WOS3
TÃTULO: Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial
AUTORES: Ladenstein, RL; Poetschger, U; Luksch, R; Brock, P; Castel, V; Yaniv, I; Papadakis, V; Laureys, G; Malis, J; Balwierz, W; Ruud, E; Kogner, P; Schroeder, H; Forjaz F De Lacerda; Beck B Popovic; Bician, P; Garami, M; Trahair, T; Pearson, AD; Valteau V Couanet;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 18
AUTORES: Ladenstein, RL; Poetschger, U; Luksch, R; Brock, P; Castel, V; Yaniv, I; Papadakis, V; Laureys, G; Malis, J; Balwierz, W; Ruud, E; Kogner, P; Schroeder, H; Forjaz F De Lacerda; Beck B Popovic; Bician, P; Garami, M; Trahair, T; Pearson, AD; Valteau V Couanet;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 18
INDEXADO EM: WOS
WOS4
TÃTULO: Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
AUTORES: Ruth Ladenstein; Dominique Valteau Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Genevieve Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck Popovic; Guenter Schreier; David Machin; Ulrike Potschger; Andrew Pearson;
PUBLICAÇÃO: 2010, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 28, NÚMERO: 21
AUTORES: Ruth Ladenstein; Dominique Valteau Couanet; Penelope Brock; Isaac Yaniv; Victoria Castel; Genevieve Laureys; Josef Malis; Vassilios Papadakis; Ana Lacerda; Ellen Ruud; Per Kogner; Miklos Garami; Walentyna Balwierz; Henrik Schroeder; Maja Beck Popovic; Guenter Schreier; David Machin; Ulrike Potschger; Andrew Pearson;
PUBLICAÇÃO: 2010, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 28, NÚMERO: 21
INDEXADO EM: WOS 
CrossRef
WOS CrossRef